Fetal Alcohol Spectrum Disorders: Screening, Assessment & Diagnosis
Fetal alcohol spectrum disorders (FASD) are among the most common preventable causes of intellectual disability and behavioral difficulty in children, yet they remain widely underrecognized in primary care. Because the neurodevelopmental forms rarely present with the recognizable facial features clinicians associate with fetal alcohol syndrome, most affected children are never identified. This clinical reference for pediatric clinicians summarizes how to screen every patient for prenatal alcohol exposure, recognize the neurobehavioral and physical features across the spectrum — including FAS, partial FAS, ARND, ARBD, and the DSM-5 category ND-PAE — and move toward an accurate diagnosis and coordinated, interprofessional care. It is adapted from a presentation by Susan Buttross, MD, FAAP, of the University of Mississippi Medical Center, developed as part of the American Academy of Pediatrics FASD education series through the AAP's Improving FASD Prevention and Practice through National Partnerships collaborative and funded by the U.S. Centers for Disease Control and Prevention, and is adapted and distributed here by the Louisiana Chapter of the American Academy of Pediatrics. Because this material reflects guidance current as of its 2016–2017 preparation, clinicians should confirm terminology and diagnostic criteria against the current DSM (DSM-5-TR) and the most recent AAP and diagnostic-guideline updates before applying them in practice.
Pediatrics from the Parishes
A Conference Reimagined
August 13 - 16, 2026
The Roosevelt Hotel • New Orleans, LA
Fetal alcohol spectrum disorders (FASD) are among the most common preventable causes of intellectual disability and behavioral difficulty in children — and are widely underrecognized in primary care. This clinician reference summarizes how to screen every patient for prenatal alcohol exposure, recognize the neurobehavioral and physical features across the spectrum, and move toward an accurate diagnosis and coordinated care.
FASD is an umbrella term, not a diagnosis. It covers a range of effects that can follow prenatal alcohol exposure (PAE), most of which involve the developing brain rather than the recognizable facial features many clinicians associate with fetal alcohol syndrome.
The FASD spectrum: terminology and diagnoses
PAE can produce a continuum of outcomes. The physical, dysmorphic presentation is the most familiar but the least common; neurodevelopmental and behavioral effects, often without any cardinal facial features, are far more prevalent.
FAS / Partial FAS
Fetal alcohol syndrome and partial FAS: characteristic facial features, central-nervous-system dysfunction or anomalies, and possible growth deficits.
ARND
Alcohol-related neurodevelopmental disorder: neurodevelopmental and behavioral effects without the cardinal dysmorphic features. Common.
ND-PAE
Neurobehavioral disorder associated with prenatal alcohol exposure: neurodevelopmental and behavioral effects regardless of dysmorphic features. A DSM-5 category. Likely common.
ARBD
Alcohol-related birth defects: congenital anomalies attributable to prenatal alcohol exposure. Rare.
ND-PAE offers the most precise description of the cognitive and behavioral picture. It was introduced as an emerging measure in DSM-5, requires confirmed prenatal alcohol exposure, and does not require the presence of physical features to be diagnosed.
Why this matters in pediatric practice
Alcohol affects fetal development and function more profoundly than most other drugs or teratogens, and its effects can be lifelong. A 1996 Institute of Medicine review concluded that among substances of abuse, alcohol produces the most serious neurobehavioral effects in the fetus. Because the neurodevelopmental forms rarely announce themselves with a recognizable face, most affected children are never identified.
Prevalence estimates put FASD well above many birth defects that pediatricians screen for routinely.
| Condition | Approximate prevalence |
|---|---|
| Spina bifida | ~1 / 1,000 |
| Down syndrome | ~1.2 / 1,000 |
| Cleft lip ± palate | ~1.2 / 1,000 |
| Autism spectrum disorder | ~12.5–14 / 1,000 |
| Fetal alcohol syndrome (FAS) | ~6–9 / 1,000 |
| All FASDs | ~24–48 / 1,000 |
| Population | FAS | All FASD |
|---|---|---|
| General (Midwestern community sample) | 6–9 / 1,000 | 24–48 / 1,000 (2.4–4.8%) |
| Children in child welfare | 60 / 1,000 (6%) | 169 / 1,000 (16.9%) |
Community estimates from May et al., 2014; child-welfare estimates from Lange et al., 2013.
How prenatal alcohol affects the brain
Prenatal alcohol exposure can disrupt many brain regions, which helps explain the wide range of cognitive, regulatory, and adaptive difficulties seen across the spectrum.
When to consider an FASD
- Developmental, cognitive, or behavioral concerns
- Complex medical concerns (for example, cardiac anomalies)
- Growth deficits
- A history of maternal alcohol or drug use
- A sibling already diagnosed with an FASD
- Dysmorphic facial features associated with FAS
Screening: taking an exposure history
Obtaining a history of in-utero alcohol exposure before problems are suspected is ideal. Fold family, social, and pregnancy history into routine assessment, and work through all potential exposures — parental concerns, medications, environmental, and recreational drugs and alcohol. Because alcohol is often consumed before a pregnancy is recognized, ask specifically about that window.
Ask openly, not defensively. Use open-ended framing — for example, inviting the parent to describe their alcohol use in the three months before they knew they were pregnant — rather than leading questions that signal an expected "no." Ask about a partner's drinking as well, and reassure the family that knowing the full picture simply helps you provide the best possible care.
Bright Futures screening questions
The AAP's Bright Futures guidelines suggest three screening questions adaptable to the pediatric setting:
- How often is beer, wine, or liquor consumed in the household?
- In the three months before the pregnancy was known, how many times were four or more drinks consumed in a day?
- During the pregnancy, how many times were four or more drinks consumed in a day?
A positive response invites follow-up on amount, frequency, and timing for diagnostic purposes. Reasonable contact points include prenatal visits, the earliest well-child visits, all new-patient visits, and any time a related concern arises.
Practice compassion. Fear of judgment is a leading reason parents do not disclose drinking during pregnancy. Be gentle and non-judgmental, share information matter-of-factly, and use person-first language — a "child with an FASD," never an "FASD kid."
Neurobehavioral features
Neurocognitive deficits
Low IQ or developmental delay; executive-function deficits; impaired learning and memory (especially visual-spatial and math); motor delays in younger children.
Self-regulation problems
Difficulty self-soothing and sleeping; trouble managing mood; behavior-management challenges; attention problems (especially shifting attention); poor impulse control.
Adaptive-skill delays
Communication deficits, especially social communication such as understanding idioms or jokes; difficulty with social skills, self-care, and daily-living skills; motor issues in younger children.
Physical features
When present, physical findings can include pre- or postnatal weight and/or length growth deficiency and abnormal brain structures (notably a small cranium and corpus callosum abnormalities). The cardinal dysmorphic facial features of FAS are:
- Short palpebral fissures
- Smooth philtrum
- Thin vermilion border (thin upper lip)
Assessment domains and diagnostic schema
A full evaluation draws on four domains: prenatal alcohol exposure history, central-nervous-system involvement (structural, neurologic, functional), growth, and dysmorphic facial features. Established diagnostic schemes — including the updated clinical guidelines of Hoyme et al. (Pediatrics, 2016) and the Canadian guidelines (Cook et al., CMAJ, 2015) — combine these domains differently across the spectrum.
| Diagnosis | Confirmed exposure | Facial features | Growth deficit | CNS / cognitive involvement |
|---|---|---|---|---|
| FAS | Not required | Required (all three) | Growth deficit and/or CNS involvement | Structural, neurologic, or functional |
| Partial FAS | With or without | Some facial features | Plus growth deficit or CNS involvement or behavioral/cognitive findings | |
| ARBD | Required | — | Specific congenital anomalies (e.g., cardiac); rare | |
| ARND | Required | — | — | Neurodevelopmental / behavioral effects |
| ND-PAE | Required | Not required | Not required | As defined in DSM-5 (neurocognition, self-regulation, adaptive function) |
Conceptual summary only; apply the full published criteria (Hoyme et al., 2016 and the schema adapted in Pediatrics, 2000) when making a diagnosis. Only FAS can be diagnosed without confirmed in-utero alcohol exposure.
Record review and history
- Exposure history
- Birth records (weight, length, head circumference)
- Medical history and records (birth defects? exposures?)
- Postnatal growth records
- Developmental and behavioral history
- Psychological testing, including cognitive and behavioral assessment
Differential and comorbid diagnoses
Behavioral
ADHD, intellectual disability, early trauma, conduct disorder / oppositional defiant disorder, and parenting-related factors.
Genetic & growth
Williams syndrome, Dubowitz syndrome, fetal valproate syndrome, maternal PKU fetal effects, nutritional insufficiency, and prenatal smoking.
Delivering the diagnosis and next steps
Approach the conversation as you would any diagnosis with lasting impact on a child's future. Sensitivity to potential stigma is essential, particularly when the biological mother is involved. Explaining how the diagnosis opens the door to treatment and better parent–child interaction is helpful. Naming a biological cause can also bring parental relief, direct families toward evidence-based interventions, avoid unnecessary testing, and — in conversation with a biological mother — reduce recurrence risk in future pregnancies.
Once a diagnosis is established, counsel families about the natural history of neurodevelopmental manifestations over time and the importance of early intervention to prevent secondary conditions. Anchor ongoing care in the medical home.
Referrals
For diagnosis, when findings are uncertain: an FASD diagnostic clinic, genetics/dysmorphology clinic, neurodevelopmental-behavioral pediatrician, or neuropsychologist/behavioral psychologist for ND-PAE or ARND. For treatment and care planning: neuropsychology or clinical/school psychology, early intervention, speech-language, occupational or physical therapy as indicated, social work, and medical specialists (for example, otolaryngology for recurrent ear infections). Care is best delivered by an interprofessional team working toward a shared goal, with the patient and family treated as team members.
Take-home points
- FASD is more common than recognized — most practices care for affected children.
- A prenatal alcohol-exposure history is good practice and should be routine for every patient.
- Most affected children present with neurodevelopmental or neurobehavioral problems rather than facial features.
- A comprehensive physical and behavioral assessment is the best route to an accurate diagnosis and care plan.
Source. Adapted from "Fetal Alcohol Spectrum Disorders: Screening, Assessment and Diagnosis," presented by Susan Buttross, MD, FAAP (University of Mississippi Medical Center), part of the American Academy of Pediatrics FASD education series developed through the AAP's Improving FASD Prevention and Practice through National Partnerships collaborative and funded by the National Center on Birth Defects and Developmental Disabilities at the U.S. Centers for Disease Control and Prevention. Adapted and distributed by the Louisiana Chapter of the American Academy of Pediatrics.
Currency note. This material reflects guidance current as of its 2016–2017 preparation, including the Hoyme et al. (2016) diagnostic guidelines and DSM-5. Clinicians should confirm terminology and criteria against the current DSM (DSM-5-TR) and the most recent AAP and diagnostic-guideline updates before applying them in practice.